Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes it does
After today's action, you still believe $ 5.67 is not the pivot point?
So it was...but did you short it or take a position to go long?
I picked up 3 more positions as it bottomed out on the long side.
Since then the total short is 4.5 million less than it was last month,but they have 5.7 days to cover.
self will run rampant
That is the true philosophy of trading.
You do not trade the markets, you trade on your beliefs.
So yes that is my belief along with my calculation of where it is likely to have support.
Good luck with that number
$ 5.67 is the pivot from the $300 high Tilray hit.
self will run rampant
Maybe...because they are a multi level marketing company.
From their own INTR...
(arijuana Company of America, Inc. has developed Club Harmoneous to deliver all the benefits of cannabis conveniently and discreetly. Through MCOA's Managed Services, the Company offers Marketing Services designed to increase membership. This is done through an affiliate referral program where members refer new member patients and earn discounts and income.
Using a buyers club format, individuals have access to a wide variety of high quality cannabis flower (buds), concentrates and accessories. If you are a patient with a valid doctor's recommendation, your "doctor's rec" will be validated when you sign up and are linked to a Club Harmoneous Affiliate. The requirements and regulations vary state-to-state, in California and other MMJ states you will need a valid doctor's medical marijuana recommendation. You may obtain a convenient recommendation online with a discount from our partners at HelloMD.com.
Looky,looky, what article I found on how CBD may stop Covid infections.
https://www.eatthis.com/covid-cannabis-help-infection/
Very good...
Can you imagine the amount of stock that now acts as resistance?
ITs a LOT..
Took my profit one hour ago...
self will run rampant
Question...
If you 'normally trade Pennies', what happens when a stock rises real fast after being flat for a long time?
And why ask for trading advice if this is what you normally do?
both BID & ASK are trading in 4 digits!!
You know what that means...
self will run rampant
And seconded...motion is passed
Chairman...the floor is yours!
O.K Technical crap forgotten .
It's going bankrupt!
rampant run will self
Actually, it just officially made a double bottom.
self will run rampant
You all still don't get it... (they) somebody is trading and hedging between MCOA & GOHE.
self will run rampant
" Patriot One provides corporate update."
* But.. I won't post the URL..LOL
self will run rampant
Hasn't anyone read the INTRO on the CEO and Co-founder being high volume traders...what do yo expect?
self will run rampant
CBD Producers Jumping the Pond to Capitalize on Potential Multi-Billion-Dollar EU CBD Market
Search News
Enter symbol...
Search
Article Tools
Set News Alert
Companies Mentioned
Symbol Last Change
MCOA $0.0113 -3.42%
OGI $6.21 -0.92%
Back to News Overview
CBD Producers Jumping the Pond to Capitalize on Potential Multi-Billion-Dollar EU CBD Market
6/14/19 3:38 PM ET (PR NewsWire)Print
Much has changed in the aftermath of the World Health Organization's (WHO) marijuana reclassification recommendation back in February -- in particular, the potential for the European Union (EU) CBD market. Products made from the non-psychoactive cannabinoid are growing in popularity in the EU, through innovation and perseverance from North American companies such as StillCanna Inc. (CSE:STIL) (OTCPK:SCNNF), Marijuana Company of America, Inc. (OTCQB:MCOA), ICC International Cannabis Corp. (OTCPK: WLDCF) (CSE: WRLD.U), OrganiGram Holdings Inc. (NASDAQ: OGI) (TSX. V:OGI) and Aleafia Health Inc. (OTCQX: ALEAF) (TSX: ALEF).
Europe's CBD market potential is startlingly large. Leading market intelligence firm Brightfield Group predicts the estimated $318 million market (2018) to grow +400% through 2023 and be at least 2 times larger than the U.S. market. It's an opportunity not lost upon producers, such as StillCanna Inc. (CSE:STIL) (OTC:SCNNF) that has already accumulated EU CBD assets in the UK, Romania, and Poland, leading to lucrative global supply deals.
Positive momentum for CBD and medical cannabis is growing, as the WHO recommendation was soon followed by a non-binding resolution voted on (and passed) by the European Parliament.
"CBD is just starting to take hold in Europe, with both product availability and consumer awareness still quite limited," says Brightfield Managing Director, Bethany Gomez. "This is a great opportunity for developed brands to enter and expand through Europe with far less competition than we're seeing in the U.S. ... CBD has been well received on a greater scale, especially in countries that already have medical or recreational cannabis programs and there are growing efforts in countries with no cannabis or CBD programs to have one or both in the coming years."
So far, the largest CBD markets in Europe are in the United Kingdom and Austria, while Switzerland and Spain are building out and improving regulations surrounding product quality. With a population of more than 740 million people, the European market is home to more than double that of the combined populations of the United States and Canada.
Joining StillCanna Inc. (STIL-SCNNF) in the race to stake EU ground are companies both large and small, including both Marijuana Company of America, Inc. (OTCQB:MCOA), and ICC International Cannabis Corp. (OTCPK:WLDCF) (CSE:WRLD.U.CN) who have also gained ground in the UK.
Back in March, MCOA's wholly-owned subsidiary hempSMART officially launched its industrial hemp-formulated CBD products in the UK.
Perhaps more diversified are the EU assets of ICC with cultivation, extraction, formulation and distribution assets in the UK, but also in Denmark, Poland, Switzerland, Germany, Greece, Italy, Portugal, Malta, and Bulgaria--which is likely set to become the first country in Europe to permit the sale of hemp-derived CBD nutraceutical products on the open market.
Other companies are finding their own entry-points into the EU market, such as OrganiGram's (NASDAQ:OGI) (TSX.V:OGI) investment into Serbian-based Eviana Health Corporation to jointly produce high-potency CBD oils, pharmaceuticals, nutraceuticals, topical creams, and health products. In May, Aleafia Health Inc. (OTCQX:ALEAF) (TSX:ALEF) saw its shares get a boost upon announcing its entry into the German medical cannabis market through a joint venture with Acnos Pharma GmbH, a German pharmaceutical wholesale, in a market that's still sorting out its own legality over the cannabinoid.
Leveraging the EU CBD Market
Back in May, StillCanna Inc. (STIL-SCNNF) signed a definitive agreement to supply Bioscience Enterprises of California with up to CAD$36 million worth of CBD isolate. The deal was the first major announcement after StillCanna had only officially acquired Polish hemp producer Olimax, just weeks prior.
The Olimax addition gave StillCanna a vertically-integrated licensed cultivator, extractor and formulator of CBD, and a team with a core strength of agriculture expertise with hemp. As well, the acquisition resulting in the planting of 1,500 hectares of land in Poland using the company's proprietary hemp varietal, with an expected harvest in early August.
What the company does with that harvest will likely be even more impressive.
According to an April 2019 Hemp Benchmarks report, the wholesale price per kilogram for hemp isolate in the United States was $6,077 per kg. StillCanna has mastered the production process, to produce hemp isolate for a paltry CAD$500 per kg.
With a forecasted production potential estimated to eclipse 16,000 kg in 2019, the company's forecasted production value can be expected to be more than $97 million--for an impressive profit margin of over 824%.
Beyond the Bioscience Enterprises of California deal, StillCanna has also secured a lucrative deal with UK-based Dragonfly BioSciences, LLC, which in March increased its monthly order to over 170 kgs per month for the next quarter. Now with a strategic relationship signed with Sarah Yetman, an expert in the international transportation of industrial hemp and CBD, StillCanna is looking to secure further international shipments and supply deals on a global scale.
"We are very impressed with the infrastructure that Sarah has been able to establish in both the USA and abroad," stated Jason Dussault, CEO of StillCanna. "Her expertise and experience provides an invaluable service to StillCanna and is an important link in our supply chain. This relationship allows our products to reach a wider international audience. Ms. Yetman also brings a broad international base of buyers for both CBD products and hemp biomass."
"I couldn't be more pleased to be working with StillCanna and providing them with the global logistics they require," said Sarah Yetman. "The contacts and infrastructure I have established is a custom fit for both the Company and myself. I look forward to implementing and overseeing the first of many shipments."
As the EU and North American markets continue to liberate the potential of CBD, deals such as those expected from Sarah Yetman and StillCanna may shorten the distance between continents. Other producers are also looking to get into the EU's CBD market, as it heads towards its predicted multi-billion-dollar potential.
Further European CBD Market Entrants
Through its wholly-owned subsidiary hempSMART, Marijuana Company of America, Inc. (MCOA) is producing industrial hemp-formulated CBD products for the UK market. In order to expedite the rollout of the hempSMART(TM) product line in Europe, MCOA has taken steps to list the subsidiary on the Vienna Stock Exchange, ahead of entering Portugal, and later France, Germany, and Austria.
Having a presence in even more EU nations, ICC International Cannabis Corp. (WLDCF) (WRLD.U) including Denmark, Poland, Switzerland, Germany, Greece, Italy, Portugal, Malta, and Bulgaria. Truly built as an international entity to live up to its namesake, ICC is also looking to innovate how CBD is purchased. The Canadian company has acquired the rights to a self-dispensing THC/CBD vending machine, which is planned to be deployed into its existing network of 80,000 high-traffic retail endpoints and pharmacies across Europe.
Coming into the EU through a unique entry point (Serbia), OrganiGram Holdings Inc. (OGI) announced its private investment in Eviana Health Corporation. The Serbian-based Eviana creates high-quality, organic CBD from natural hemp strains of cannabis sativa. It operates on a parcel of 100 hectares of Serbian agricultural land, where it grows hemp. Due to the company's license, OrganiGram gained easy access to the European market, and its significant demand for high-level CBD.
Aleafia Health Inc. (ALEAF) (ALEF) chose the high-potential medical cannabis market of Germany through a joint venture with pharmaceutical wholesaler Acnos Pharma Gmbh. Aleafia's stock price bumped upward upon the announcement of entering the EU, and the potential for production of branded cannabis oils for distribution and for usage in clinical trials. The company's expressed optimism to soon see the export of cannabis health and wellness products to the German market.
For a free research report on StillCanna Inc. (CSE:STIL) (OTC:SCNNF), visit www.potstocknews.com
Disclaimer: Potstocknews.com (PSN) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with PSN or any company mentioned herein. The commentary, views and opinions expressed in this release by PSN are solely those of PSN and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable PSN and FNM for any investment decisions by their readers or subscribers. PSN and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author (PSN), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (PSN) has not independently verified or otherwise investigated all such information. None of the Author, PSN, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by PSN, a non-affiliated third party to distribute this release on behalf of StillCanna Inc.
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act o
Six points past the decimal - good sign
Hey 32001;
Sorry for your loss,but Pinksheets have no market per sey.
They sometimes follow in tamdem the NASDAQ because of interpolated stocks like technology,pharmacies,etc. but they are not an under lying asset producing equity of any index
Hopefully that will change soon.
self will run rampant
I'm with you bra'
Got mine this morning to fulfill my 1 million share build-up.
What to do now?!!!
Sit back and smoke about it?
self will run rampant
I'd watch my indicators more closely after lunch !
selfwill run rampant
Sorry...memory fart
They filed for a patent (not granted one,yet)
This is turning out to be a "dead cat bounce."
self will run rampant
Nope, 1st day here.
Just looked at the chart and saw a possible entry point and then 30 minutes later, the press release comes out.
Self will run rampant
Don't flatter yourself.
Press release just came out!
Well said !!
Self will run rampant
Weebles wobble ,but they don't fall down!
Self will run rampant
that was a quick response.
Tells me you're a trader like the rest of us.
best of luck to you and I see a set up occuring to the long side.
What will happen when the price per share won't get below the $1.20 that it touched today?
Will you then change you your outlook or is this rant going to go on day after day,week after week?
What just happened to account balances? Balances and saved orders disappeared !
I have nothing,...except the last candle of your chart!
The others on here have some pretty damn good info going.
* Full disclosure- 10,000 sh. and adding.
selfwill run rampant
Will that become the infamous "Falling knife?"
What the hell...I have only 3 free articles remaining?
What was his problem??
My Ameritrade acct. says the same thing.
If you'll look at the TAB on your ameritrade acct. that says FUNDEMENTALS, you'll see that the float and the outstanding shares.
At this point,we have two differing short multipliers until new numbers come out the middle of next month.
It was this article from Yahoo Finance on Dec. 18th under "bearish sentiment"
https://finance.yahoo.com/news/see-ihs-markit-score-report-130818620.html
That's a fact...hoo rhaa
In my opinion, it's too risky.
EGO just made it's bottom and is just now creating the first of many continuation patterns.
There is no "short interest" in EGO according to reports,so what you are profiting on is the new buyers that are building this cup&handle formation.
Just as double or triple the volume signaled the rise..the same amount when short sellers make their move will signal a profit taking move...that is if you are trying to capture the longest uptrend.
Patiennce grasshopper.
Do you ALL feel LFIN went up too much ,too fast, too quick?